Spike from FDA approval. Anticipate pull back to 61 fib level. MT - price target is 61 feb extension level.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
